2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
46
Carcinoma, Transitional Cell
3
Urologic Diseases
2
Urinary Bladder Diseases
2
Muscle Invasive Bladder Cancer
2
Infiltrating Bladder Urothelial Carcinoma
2
Carcinoma, Renal Cell
2
Wound Infection
1
Urologic Neoplasms
1
Urinary Tract Infections
1
Ureteral Neoplasms
1
Transitional Cell Carcinoma of the Bladder
1
Transitional Cell Bladder Cancer
1
Stage 0is Bladder Urothelial Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Patient Satisfaction
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non-metastatic Muscle Invasive Bladder Cancer
1
Neoplasms
1
Invasive Bladder Cancer
1
Infections
1
Ileus
1
Disease Progression
1
Cross Infection
1
Cone Dystrophy 3
1
Bladder Adenocarcinoma
1
Bacterial Infections
1
Adrenal Gland Neoplasms
1
Interventions
avelumab
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-metastatic Muscle Invasive Bladder Cancer
×
Cystectomy
×
Clear all
NCT03674424
2025-02-26
AURA
Jules Bordet Institute
Phase 2
Completed
137 enrolled